Beschreibung
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) of HIV-1 are an important part of currently available anti-HIV therapies because of their diversity and specificity in targeting this enzyme. The use of NNRTIs in the clinic still remains subject to the rapid emergence of drug resistance due to mutation of the HIV-RT enzyme and this limits therapeutic options. So there is need to discover new chemical entity having broad spectrum activity against reverse transcriptase enzyme.
Autorenporträt
Dr. Santosh N. Mokale, M.Pharm Ph.D. is working as Professor at Y. B. Chavan College of Pharmacy, Aurangabad (MS). He has around 17 years of professional experience and has published 30 research papers with cumulative impact factor more than 50. He is recipient of YOUNG SCIENTIST award from DST and research grants Rs. 45 Lack from DST and UGC
Herstellerkennzeichnung:
OmniScriptum SRL
Str. Armeneasca 28/1, office 1
2012 Chisinau
MD
E-Mail: info@omniscriptum.com
![Produktbild: 2-Substituted 1H-benzo[d]imidazoles as a monodentate ligands](http://medien.umbreitkatalog.de/bildzentrale/978/620/031/2013.jpg)
![Produktbild: SYNTHESE VON BENZO [D] IMIDAZOL-SUBSTITUIERTEN DERIVATEN](http://medien.umbreitkatalog.de/bildzentrale/978/620/486/2668.jpg)
![Produktbild: 2-Substituierte 1H-Benzo[d]imidazole als monodentate Liganden](http://medien.umbreitkatalog.de/bildzentrale/978/620/506/7901.jpg)
